Sp468
CAN WE MEASURE INTESTINAL PERMEABILITY IN CLINICAL RESEARCH AND PRACTICE?
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
INTRODUCTION
SOCIETY: AGA
MANOMETRIC DIAGNOSIS AND TREATMENT OF RETROGRADE CRICOPHARYNGEAL DYSFUNCTION (R-CPD).
Dysphagia and chest pain are the common symptoms in achalasia. The mechanisms underlying such symptoms are not completely understood. The two symptoms can be triggered by mechanical stimulation via the sensory vagal and spinal afferent nerve fibers…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…